Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface | Acta Pharmacologica Sinica
Thyroid Hormones (T3 and T4): Dual Effect on Human Cancer Cell Proliferation | Anticancer Research
Dr Ruxandra Dobrescu - Săptămâna asta vorbim de analizele de tiroidă! Care sunt ele, când avem nevoie de ele și cum trebuie să le facem! 😊 Primul lucru de ținut minte? Nu
Hormoni tiroidieni | Comercializare reactivi si consumabile pentru laboratoarele de analize medicale
I.v.-infused T4-CAR T cells cause inflammation in healthy organs (A)... | Download Scientific Diagram
c-Met is highly phosphorylated in SKOV3/T4 cells and confers increased... | Download Scientific Diagram
CD4 Monoclonal Antibody (RPA-T4), PE (12-0049-80)
Frontiers | Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia
Plasma 3,3',5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two cases of metastatic cancer of the breast and pancreas treated with exogenous L-T3 - IOS Press
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast | Nature Communications
Markerii tumorali | Reginamaria.ro
A novel prognostic model for papillary thyroid cancer based on epithelial–mesenchymal transition‐related genes - Liu - Cancer Medicine - Wiley Online Library
Analize medicale - Markeri tumorali | Bioclinica
Thyroid Hormones (T3 and T4): Dual Effect on Human Cancer Cell Proliferation | Anticancer Research
Tumor Markers – Controllab
Cancers | Free Full-Text | EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) | HTML
Antitumor Activities of Immune Costimulatory Molecules of TNF Superfamily in Colorectal and Lung Cancers
Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain | Nature Cancer
Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squamous cell carcinoma - Translational Research
Frontiers | Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics